Skip to main content

Research Repository

Advanced Search

Outputs (3)

Hypoxic Neuroinflammation in the Pathogenesis of Multiple Sclerosis (2025)
Journal Article
Hollingworth, B. Y. A., Pallier, P. N., Jenkins, S. I., & Chen, R. (in press). Hypoxic Neuroinflammation in the Pathogenesis of Multiple Sclerosis. Brain Sciences, 15(3), Article 248. https://doi.org/10.3390/brainsci15030248

Multiple sclerosis (MS) is an autoimmune disease that damages the myelin sheath around the central nervous system axons, leading to neurological dysfunction. Although the initial damage is driven by inflammation, hypoxia has been reported in several... Read More about Hypoxic Neuroinflammation in the Pathogenesis of Multiple Sclerosis.

Socioeconomic deprivation and survival after stroke in China: a systematic literature review and a new population-based cohort study (2015)
Journal Article
Chen, R., Hu, Z., Chen, R., Zhang, D., Xu, L., Wang, J., & Wei, L. (2015). Socioeconomic deprivation and survival after stroke in China: a systematic literature review and a new population-based cohort study. BMJ Open, 5(1), Article e005688. https://doi.org/10.1136/bmjopen-2014-005688

OBJECTIVE: To assess the association of socioeconomic deprivation (SED) with survival after stroke in China. DESIGN: A systematic literature review and a new population-based cohort study. SETTING AND PARTICIPANTS: In urban and rural communities in A... Read More about Socioeconomic deprivation and survival after stroke in China: a systematic literature review and a new population-based cohort study.

Stem cell therapy for ischaemic stroke: translation from preclinical studies to clinical treatment (2013)
Journal Article
Balami, J. S., Fricker, R. A., & Chen, R. (2013). Stem cell therapy for ischaemic stroke: translation from preclinical studies to clinical treatment. CNS & Neurological Disorders - Drug Targets, 12(2), 209 -219. https://doi.org/10.2174/1871527311312020007

No pharmacological intervention has been shown convincingly to improve neurological outcome in stroke patients after the brain tissue is infarcted. While conventional therapeutic strategies focus on preventing brain damage, stem cell treatment has th... Read More about Stem cell therapy for ischaemic stroke: translation from preclinical studies to clinical treatment.